Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bryostatin-1 in Recurrent Non-Hodgkin's Lymphoma
NCT00002725Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Aug 1996
- Primary completion
- Apr 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bryostatin-1 in non-Hodgkin lymphoma (NHL), sponsored by National Cancer Institute. Primary endpoint: Response to bryostatin 1. Started Aug 1996; status: completed.
02
Drugs
bryostatin-1
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00002725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002725.